Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hydrophobic modified pres-derived peptides of hepatitis B virus (HBV) and their use as HBV and HDV entry inhibitors

Hydrophobic modified pres-derived peptides of hepatitis B virus (HBV) and their use as HBV and HDV entry inhibitors

US Patent 9562076 · Granted Feb 7, 2017

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lipopeptides for use in treating liver diseases and cardiovascular diseases2025
Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agent2024
Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for th2024
Method and means for the rapid detection of HDV infections2023
Cyclic NTCP-targeting peptides and their uses as entry inhibitors2022
Cyclic NTCP-targeting peptides and their uses as entry inhibitors2022
Methylglyoxal-scavenging cyclic peptides and their use for the prevention and tr2021
Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for th2021
Lipopeptides for use in treating liver diseases and cardiovascular diseases2021
Liposomal formulation for the oral hepatic delivery of drugs2020
Liposomal formulation for the oral hepatic delivery of drugs2020
CD44v6-derived cyclic peptides for treating cancers and angiogenesis related dis2020